课题基金 / 基金详情

Co-administration of pramlintide and insulin via an automated dual hormone artificial pancreas system to regulate glucose levels in adults with type 1 diabetes

Co-administration of pramlintide and insulin via an automated dual hormone artificial pancreas system to regulate glucose levels in adults with type 1 diabetes
通过自动双激素人工胰腺系统联合施用普兰林肽和胰岛素来调节成人 1 型糖尿病患者的血糖水平
批准号：
500273
负责人：
El Maalouli Jimmy
金额：
$1.27万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=500273&lang=en
关键词：
Artificial Pancreas Dexcom G6 Glucose Sensor Diabetic Ketoacidosis (Dka) Dosing Algorithm Hyperglycemia Hypoglycemia Insulin Basal And Bolus Pramlintide Rapid Insulin Ypsopump

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes is a chronic disease caused by the autoimmune destruction of pancreatic beta-cells responsible for the release of various hormones, including insulin, that control one’s plasma glucose levels. Closed-loop systems are a promising therapy ch
期刊论文(0)
专著(0)
科研奖励(0)
会议论文